New to HBW Insight?
Start a free trial today!
Register for our free email digests:
Register for our free email digests:
Tom Gallen
Managing Editor – Europe
Having joined OTC bulletin as a business reporter in 2013, Tom is currently the managing editor and has an intimate knowledge of the global consumer healthcare market, particularly commercial and regulatory issues. He specializes in analyzing the strategies of the world's leading consumer healthcare companies, their business performance, plans and product portfolios.
Advertisement
Remove Alert
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Tom Gallen
Pain Relief Most Popular Reason For Using CBD In UK
Pain relief is by far the most popular reason for taking CBD in the UK, a recent survey has revealed. The research by YouGov also finds that a quarter of those who have not tried CBD are tempted to do so.
Dutch Firms Not Updating Product Info Fast Enough Following Safety Alerts
OTC marketing authorization holders in the Netherlands must respond more quickly to safety alerts issued at EU level which require product information updates, says regulator MEB.
Dutch Self-Care Efforts Stumble As Supplement Prescription Costs Rise
Costs of prescriptions for vitamin D supplements in the Netherlands are spiraling with government moves to encourage self-care appearing to have had the opposite effect, according to new research.
Boiron Warned Over Use Of Social Media Influencer In French Ad
Using a social media influencer to promote its pro-homeopathy campaign in France without clearly indicating the post was a paid ad has landed Boiron in hot water with local regulators.
Takeda Offloads Emerging Market OTCs to Acino
Takeda is shedding some unwanted OTC assets in a number of emerging markets as part of its efforts to pay down debt and focus its portfolio following its acquisition of Shire.
Brazil Prepares To Clear Backlog Of 25 Switch Applications
Brazil's drug regulator Anvisa is seeking comments on its backlog of 25 Rx-to-OTC switch applications as it looks to make more prescription products available OTC.
Advertisement